Compare Ginkgo Bioworks Holdings Inc (DNA) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Wheaton Precious Metals Corp — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.28 (market cap $505.73M), while Wheaton Precious Metals Corp trades at $134.1 (market cap $60.94B). The key difference: Wheaton Precious Metals Corp is far larger — about 120.5× Ginkgo Bioworks Holdings Inc's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | WPM | |
|---|---|---|
Market Cap | $505.73M | $60.94B |
Sector | Health | Basic Materials |
52-Week High | $16.14 | $165.72 |
52-Week Low | $5.48 | $91.02 |
Enterprise Value | $607.68M | $62.82B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $7.21, down 5.75% today, amid bearish technical signals and weak fundamentals. The company reported Q2 2026 revenue of $20 million, down 48% year-over-year, with persistent losses and negative cash flow. Analyst sentiment is mixed with 45% buy ratings but significant sell-side coverage, while technical indicators show strong bearish momentum with support at $7.
DNA faces substantial execution risks as it pivots to autonomous lab services, with negative profitability metrics and declining revenue creating headwinds. The stock's valuation appears stretched relative to fundamentals, though recent earnings beats offer some optimism. Investors should weigh the company's long-term biotech potential against near-term financial challenges.
Wheaton Precious Metals (WPM) trades at $135.00, up 1.21% on the day, with a bullish technical signal supported by moving averages. The company reported record first-half 2026 results, with Q2 earnings of $1.19 per share beating estimates, driven by higher metal prices and sales volumes. Strong profitability is evident with a net income margin of 64.66% and robust cash flow from operations of $1.90 billion in 2025. Analyst consensus is strongly positive with a buy rating from 80% of covering firms and a price target of $161.75.
The outlook remains favorable given sustained high precious metal prices and operational execution, though elevated valuation multiples and potential commodity price volatility present risks. Upside is supported by consistent earnings beats and institutional confidence, but investors should weigh the stock's premium pricing against growth sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
